FOCUS magazine, Germany:
Quote:
Top news (10:31 p.m.): The scientists of the German Primate Center (Leibniz Institute for Primate Research) in Göttingen identified a possible drug against the novel corona virus in a study. First of all, the researchers discovered a cellular enzyme that is essential for the virus to enter the lung cells - the protease TMPRSS2.
An existing drug that can inhibit this enzyme could therefore be a promising treatment option, the scientists continue. The drug, which is called Camostat Mesilate, has already been approved in Japan. The researchers are now investigating whether it can prevent infection with SARS-CoV-2. "We tested SARS-CoV-2 from a patient and found that Camostat Mesilate blocks the virus from entering the lung cells," says Markus Hoffmann, first author of the study.
|
Case number in Germany: 400-500. The Robert-Koch Institute (=German CDC) and the health ministry of Northrhine-Westfalia disagree over the numbers.